2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
August 17th 2020
Denise Yardley, MD, discusses the role of endocrine therapy in combination with CDK4/6 inhibitors in patients with hormone receptor–positive, HER2-negative breast cancer and visceral metastases.
June 15th 2020
Denise Yardley, MD, discusses treatment considerations for patients with advanced breast cancer who have visceral metastases.
January 16th 2020
Denise Yardley, MD, discusses the utility of CDK4/6 inhibitors in hormone receptor